MARKET

SUPN

SUPN

Supernus Pharma
NASDAQ
48.27
+1.12
+2.38%
After Hours: 48.27 0 0.00% 19:34 08/14 EDT
OPEN
46.70
PREV CLOSE
47.15
HIGH
48.39
LOW
46.57
VOLUME
331.73K
TURNOVER
--
52 WEEK HIGH
59.68
52 WEEK LOW
40.32
MARKET CAP
2.81B
P/E (TTM)
-25.2155
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at SUPN last week (0803-0807)?
Weekly Report · 4d ago
Key deals this week: Bending Spoons, Advanced Micro Devices, Visa, Prologis, and more
Seeking Alpha · 5d ago
SUPN vs. TEVA: Which Stock Should Value Investors Buy Now?
NASDAQ · 08/07 15:40
Supernus Pharmaceuticals Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Supernus Pharmaceuticals, Inc. - SUPN
Barchart · 08/07 10:21
New Strong Buy Stocks for August 7th
NASDAQ · 08/07 08:46
Carillon Chartwell Small Cap Growth Fund Q2 2026 Portfolio Review
Seeking Alpha · 08/07 07:55
Best Value Stocks to Buy for August 7th
NASDAQ · 08/07 07:45
Top 3 Health Care Stocks You'll Regret Missing This Quarter
Benzinga · 08/04 10:04
More
About SUPN
Supernus Pharmaceuticals, Inc. is a biopharmaceutical company focused on developing and commercializing products for the treatment of central nervous system (CNS) diseases. The Company's diverse neuroscience portfolio includes approved treatments for attention-deficit hyperactivity disorder (ADHD), dyskinesia in Parkinson's Disease (PD) patients receiving levodopa-based therapy, hypomobility in PD, postpartum depression (PPD), epilepsy, migraine, cervical dystonia, and chronic sialorrhea. The Company is developing a range of CNS product candidates including new potential treatments for epilepsy, depression, ADHD, and other CNS disorders. Its products marketed in the United States include Qelbree, GOCOVRI, Oxtellar XR, Trokendi XR, APOKYN, XADAGO, MYOBLOC, ONAPGOTM (formerly known as SPN-830), and ZURZUVAE. Qelbree (viloxazine extended-release capsules) is a non-stimulant product indicated for the treatment of ADHD in adults and pediatric patients 6 years and older.

Webull offers Supernus Pharmaceuticals Inc stock information, including NASDAQ: SUPN real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, SUPN stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading SUPN stock methods without spending real money on the virtual paper trading platform.